Trial Profile
Ticagrelor and absorb bioresorbable vascular scaffold implantation for recovery of vascular function after successful chronic total occlusion recanalization.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Arterial occlusive disorders; Coronary disorders
- Focus Therapeutic Use
- Acronyms TIGER-BVS
- 17 Nov 2020 Results assessing long-term vascular function in coronary total occlusion recanalization presented at the American Heart Association Scientific Sessions 2020
- 24 Sep 2019 Status changed from active, no longer recruiting to completed.
- 01 Jan 2018 Trial design of the study published in the Catheterization and Cardiovascular Interventions.